)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
The proposed social-media scrutiny and suspension of student visa interviews could lead to delays in the application process for Indian students
The country clocked 752 new Covid-19 infections between May 19 and 26, seven deaths reported during the period
The institute becomes the second UK university after Southampton to get UGC approval; 15 foreign varsities to open India campuses this academic year, says Pradhan
Harvard currently hosts around 10,158 international students and scholars across its schools. Of these, 788 -- the second-largest cohort after China -- are from India, according to university data
Masks, tests and advisories return as states like Kerala, UP and Odisha increase vigilance amid rising Covid-19 cases driven by new Omicron sub-variants
Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance
Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles
Strong chronic therapy performance, BSV consolidation drive revenue growth in Q4; net profit declines 10 per cent year-on-year to Rs 425 crore
Monthly CDSCO alert identifies 196 batches of drugs as not of standard quality and flags one Deca-Durabolin injection as spurious and under investigation
The hospital chain's revenue rose 12.4% to Rs 2,007 crore in Q4 FY25 driven by hospital and diagnostics segments, but higher expenses and impairments hit net profit
India records 164 new Covid-19 cases between May 12 and 19, with Kerala, Tamil Nadu and Maharashtra reporting most cases; officials say symptoms remain mild
IHH arm NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore, alleging obstruction of Fortis Healthcare acquisition via stalled open offer
Projects like The Dahlias and Privana West fuelled DLF's FY25 sales to a record Rs 21,223 crore, with strong demand from domestic buyers and NRIs
Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities
Lupin plans to expand complex generics in developed markets and grow its chronic drug portfolio in India, with over 200 product launches and M&A on the radar
Fully AI-integrated project in Greater Noida
DLF posts robust Q4FY25 results with 39% rise in profit and 46% growth in revenue, driven by record sales from luxury projects and steady rental performance
Govt says Covid-19 situation remains under control despite a minor uptick in cases, amid rising infections in Singapore and Hong Kong attributed to Omicron subvariants
Doctors advise calm as India sees just 58 new Covid-19 cases amid a rise in HK and Singapore; experts highlight low hospitalisation and no serious strain currently
Data centres and hospitals are key growth drivers for EPC firm Capacit'e Infraprojects as it enters global markets after its first international project in Maldives